Literature DB >> 19770513

B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice.

Daniel P Ankeny1, Zhen Guan, Phillip G Popovich.   

Abstract

Traumatic injury to the mammalian spinal cord activates B cells, which culminates in the synthesis of autoantibodies. The functional significance of this immune response is unclear. Here, we show that locomotor recovery was improved and lesion pathology was reduced after spinal cord injury (SCI) in mice lacking B cells. After SCI, antibody-secreting B cells and Igs were present in the cerebrospinal fluid and/or injured spinal cord of WT mice but not mice lacking B cells. In mice with normal B cell function, large deposits of antibody and complement component 1q (C1q) accumulated at sites of axon pathology and demyelination. Antibodies produced after SCI caused pathology, in part by activating intraspinal complement and cells bearing Fc receptors. These data indicate that B cells, through the production of antibodies, affect pathology in SCI. One or more components of this pathologic immune response could be considered as novel therapeutic targets for minimizing tissue injury and/or promoting repair after SCI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770513      PMCID: PMC2752085          DOI: 10.1172/JCI39780

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury.

Authors:  K C Hayes; T C L Hull; G A Delaney; P J Potter; K A J Sequeira; K Campbell; P G Popovich
Journal:  J Neurotrauma       Date:  2002-06       Impact factor: 5.269

2.  Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.

Authors:  K-B Abdul-Majid; A Stefferl; C Bourquin; H Lassmann; C Linington; T Olsson; S Kleinau; R A Harris
Journal:  Scand J Immunol       Date:  2002-01       Impact factor: 3.487

3.  Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord.

Authors:  I Dusart; M E Schwab
Journal:  Eur J Neurosci       Date:  1994-05-01       Impact factor: 3.386

4.  Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy.

Authors:  T Bucky Jones; D Michele Basso; Ajeet Sodhi; Jonathan Z Pan; Ronald P Hart; Robert C MacCallum; Sunhee Lee; Caroline C Whitacre; Phillip G Popovich
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

5.  Rats and mice exhibit distinct inflammatory reactions after spinal cord injury.

Authors:  Julie M Sroga; T Bucky Jones; Kristina A Kigerl; Violeta M McGaughy; Phillip G Popovich
Journal:  J Comp Neurol       Date:  2003-07-21       Impact factor: 3.215

6.  The effects of anti-idiotypic antibody on antibody production and apoptosis of anti-dsDNA antibody producing cells.

Authors:  C H Lee; C H Suh; J Lee; Y T Kim; S K Lee
Journal:  Clin Exp Rheumatol       Date:  2003 May-Jun       Impact factor: 4.473

7.  Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage.

Authors:  A R Blight
Journal:  Neuroscience       Date:  1994-05       Impact factor: 3.590

8.  Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM.

Authors:  William G Austen; Ming Zhang; Rodney Chan; Daniel Friend; Herbert B Hechtman; Michael C Carroll; Francis D Moore
Journal:  Surgery       Date:  2004-08       Impact factor: 3.982

9.  Identification of light chain type bands in CSF and serum oligoclonal IgG from patients with multiple sclerosis.

Authors:  P D Mehta; S P Mehta; B A Patrick
Journal:  J Neuroimmunol       Date:  1982-04       Impact factor: 3.478

10.  Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier.

Authors:  Felix Schlachetzki; Chunni Zhu; William M Pardridge
Journal:  J Neurochem       Date:  2002-04       Impact factor: 5.372

View more
  70 in total

1.  The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice.

Authors:  Akshata Almad; A Todd Lash; Ping Wei; Amy E Lovett-Racke; Dana M McTigue
Journal:  Exp Neurol       Date:  2011-09-21       Impact factor: 5.330

2.  Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury.

Authors:  Mauricio E Vargas; Junryo Watanabe; Simar J Singh; William H Robinson; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

3.  Identification of autoantibodies to glial fibrillary acidic protein in spinal cord injury patients.

Authors:  Georgene W Hergenroeder; Anthony N Moore; Karl M Schmitt; John B Redell; Pramod K Dash
Journal:  Neuroreport       Date:  2016-01-20       Impact factor: 1.837

4.  A Rehabilomics framework for personalized and translational rehabilitation research and care for individuals with disabilities: Perspectives and considerations for spinal cord injury.

Authors:  Amy K Wagner
Journal:  J Spinal Cord Med       Date:  2014-07-16       Impact factor: 1.985

Review 5.  The role of peripheral immune cells in the CNS in steady state and disease.

Authors:  Marco Prinz; Josef Priller
Journal:  Nat Neurosci       Date:  2017-01-16       Impact factor: 24.884

6.  Low doses of IgG from atopic individuals can modulate in vitro IFN-γ production by human intra-thymic TCD4 and TCD8 cells: An IVIg comparative approach.

Authors:  Fábio da Ressureição Sgnotto; Marília Garcia de Oliveira; Aline Aparecida de Lima Lira; Luciana Bento-de-Souza; Alberto José da Silva Duarte; Jefferson Russo Victor
Journal:  Hum Vaccin Immunother       Date:  2017-04-25       Impact factor: 3.452

7.  Analgesia or addiction?: implications for morphine use after spinal cord injury.

Authors:  Sarah A Woller; Georgina L Moreno; Nigel Hart; Paul J Wellman; James W Grau; Michelle A Hook
Journal:  J Neurotrauma       Date:  2012-04-02       Impact factor: 5.269

8.  Pathogenic antibodies are active participants in spinal cord injury.

Authors:  Gregory A Dekaban; Sakina Thawer
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

9.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.

Authors:  Kevin D Beck; Hal X Nguyen; Manuel D Galvan; Desirée L Salazar; Trent M Woodruff; Aileen J Anderson
Journal:  Brain       Date:  2010-01-19       Impact factor: 13.501

10.  Involvement of the choroid plexus in the inflammatory response after acute spinal cord injury in dogs: an immunohistochemical study.

Authors:  Sarah A Moore; Michael J Oglesbee
Journal:  Vet Immunol Immunopathol       Date:  2012-07-13       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.